Literature DB >> 21509653

Distress and psychosocial needs of a heterogeneous high risk familial cancer population.

Tara E Power1, John W Robinson, Peter Bridge, Francois P Bernier, Dawna M Gilchrist.   

Abstract

In order to assess the levels of distress and psychosocial support needs of a high risk population, we undertook a study to look at both the objective and subjective levels of distress and the wants and needs of individuals from a high familial cancer risk population. Three hundred and eighteen individuals (160 affected, 158 unaffected) completed several distress and psychosocial needs questionnaires (including the Brief Symptom Inventory-18). Sixty key informants were also surveyed about their perspective on the support needs of this population. In the largely female (90%), largely HBOC syndrome group (approximately 90%), 20% had significant levels of generalized distress, with no significant differences between affected and unaffected individuals. Generalized distress was also not significantly different as a function of mutation status. Individuals who received inconclusive test results, however, were more likely to indicate somatic symptoms of distress. Those individuals who did not have social support were more likely to be those who had never had cancer and who either had a mutation, received inconclusive test results, or were not tested. Key informants were most likely to indicate that patients need more support. These results provide evidence for the importance of establishing regular psychosocial distress screening, including a focus on somatic symptoms, in such high risk populations.

Entities:  

Mesh:

Year:  2011        PMID: 21509653     DOI: 10.1007/s10897-010-9344-7

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  57 in total

1.  A new psychosocial screening instrument for use with cancer patients.

Authors:  J Zabora; K BrintzenhofeSzoc; P Jacobsen; B Curbow; S Piantadosi; C Hooker; A Owens; L Derogatis
Journal:  Psychosomatics       Date:  2001 May-Jun       Impact factor: 2.386

2.  The SCL-90 and the MMPI: a step in the validation of a new self-report scale.

Authors:  L R Derogatis; K Rickels; A F Rock
Journal:  Br J Psychiatry       Date:  1976-03       Impact factor: 9.319

3.  Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators.

Authors:  P Hopwood; F Keeling; A Long; C Pool; G Evans; A Howell
Journal:  Psychooncology       Date:  1998 Sep-Oct       Impact factor: 3.894

4.  The impact of population based screening for carriers of cystic fibrosis.

Authors:  H Bekker; G Denniss; M Modell; M Bobrow; T Marteau
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

5.  Family history of breast cancer: what do women understand and recall about their genetic risk?

Authors:  M Watson; V Duvivier; M Wade Walsh; S Ashley; J Davidson; M Papaikonomou; V Murday; N Sacks; R Eeles
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

Review 6.  A literature review of the psychological impact of genetic testing on breast cancer patients.

Authors:  Kathryn J Schlich-Bakker; Herman F J ten Kroode; Margreet G E M Ausems
Journal:  Patient Educ Couns       Date:  2005-10-19

7.  The relationship between coping strategies and anxiety in women from families with familial breast-ovarian cancer in the absence of demonstrated mutations.

Authors:  Amy Østertun Geirdal; Alv A Dahl
Journal:  Psychooncology       Date:  2008-01       Impact factor: 3.894

8.  Outcome of five years of accelerated surveillance in patients at high risk for inherited breast/ovarian cancer: report of a phase II trial.

Authors:  Melissa H Fries; B Jo Hailey; Judith Flanagan; Diane Licklider
Journal:  Mil Med       Date:  2004-06       Impact factor: 1.437

9.  The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress.

Authors:  A Cull; E D Anderson; S Campbell; J Mackay; E Smyth; M Steel
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

10.  High levels of untreated distress and fatigue in cancer patients.

Authors:  L E Carlson; M Angen; J Cullum; E Goodey; J Koopmans; L Lamont; J H MacRae; M Martin; G Pelletier; J Robinson; J S A Simpson; M Speca; L Tillotson; B D Bultz
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

View more
  4 in total

1.  Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?

Authors:  Kate A McBride; Mandy L Ballinger; Timothy E Schlub; Mary-Anne Young; Martin H N Tattersall; Judy Kirk; Ros Eeles; Emma Killick; Leslie G Walker; Sue Shanley; David M Thomas; Gillian Mitchell
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

2.  Square Pegs, Round Hole? Ensuring Fit in the AYAO Spectrum for Adolescents and Young Adults with Genetic Risk for Cancer.

Authors:  Stacy D Sanford; Mary L O'Connor; Kristin N Smith; A Elizabeth Young
Journal:  J Adolesc Young Adult Oncol       Date:  2013-09       Impact factor: 2.223

3.  Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer.

Authors:  A Brédart; J L Kop; A Depauw; O Caron; S Sultan; D Leblond; A Fajac; B Buecher; M Gauthier-Villars; C Noguès; C Flahault; D Stoppa-Lyonnet; S Dolbeault
Journal:  Br J Cancer       Date:  2013-03-05       Impact factor: 7.640

4.  Emotional impact on the results of BRCA1 and BRCA2 genetic test: an observational retrospective study.

Authors:  Sara Mella; Barbara Muzzatti; Riccardo Dolcetti; Maria Antonietta Annunziata
Journal:  Hered Cancer Clin Pract       Date:  2017-10-02       Impact factor: 2.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.